Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07856225
Recruiting
Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer
Not applicable · Colombia · 1 site
Registry update: 2 Oct 2026
NCT07252336
Recruiting
A Multicenter Study of CAR-T Cells in Primary Ph+All
Phase 2 · China · 1 site
Registry update: 4 Dec 2025
NCT05770544
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Phase 2/3 · United Kingdom · 27 sites
Registry update: 24 Nov 2025
NCT07255963
Recruiting
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
Phase 2 · China · 1 site
Registry update: 1 Dec 2025
NCT06612710
Recruiting
The Safety and Efficacy of NouvSoma001 in Ischemic Stroke
Phase 1 · China · 1 site
Registry update: 21 Jan 2026
NCT07265986
Recruiting
Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital
Not applicable · Guadeloupe · 3 sites
Registry update: 5 Dec 2025
NCT07271342
Recruiting
Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China
Not applicable · China · 1 site
Registry update: 6 Jan 2026
NCT07218146
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Phase 3 · Austria, Belgium, China, Czechia, Germany, Spain, France, United Kingdom, Greece, Italy, Japan, Netherlands, Poland, United States · 165 sites
Registry update: 16 Oct 2026
NCT07201688
Recruiting
Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.
Phase 3 · China · 1 site
Registry update: 16 Dec 2025
NCT07441291
Recruiting
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 · China · 1 site
Registry update: 27 Feb 2026
NCT07239661
Recruiting
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC
Not applicable · China · 1 site
Registry update: 20 Nov 2025
NCT07238153
Recruiting
Promoting Emotional and Autonomic Control Through Guided Breathing Exercises for Emerging Adults With Autism
Not applicable · Belgium · 2 sites
Registry update: 29 Apr 2026
NCT07474103
Recruiting
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Not applicable · China · 1 site
Registry update: 16 Mar 2026
NCT07205666
Recruiting
The Eplontersen Pregnancy and Lactation Outcomes Study
Not applicable · Germany · 1 site
Registry update: 27 Aug 2026
NCT07296484
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Phase 2 · United States · 61 sites
Registry update: 6 Oct 2026
NCT07308782
Recruiting
A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · China · 1 site
Registry update: 6 Jan 2026
NCT07448935
Recruiting
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
Not applicable · Italy · 1 site
Registry update: 6 May 2026
NCT07166094
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Phase 3 · Australia, Belgium, Brazil, Canada, Germany, Denmark, Spain, Finland, France, Greece, Israel, Italy, Japan, Lithuania, Norway, Poland, Puerto Rico, Singapore, United States · 173 sites
Registry update: 3 Nov 2026
2024-516906-47-00
Recruiting
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Phase 2/3 · Austria, Belgium, Czechia, Germany, Denmark, Spain, France, Greece, Italy, Netherlands, Norway · 123 sites
Registry update: 29 Oct 2026
NCT06574620
Recruiting
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
Not applicable · Canada · 1 site
Registry update: 16 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.